Related Experiment Video
Updated: Aug 8, 2025
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Daptomycin for the treatment of acute bacterial meningitis: A narrative review
Rami H Jaber1, Nathan P Beahm1
1Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.
Background:
There is growing interest in the utilization of daptomycin for the treatment of multi-drug-resistant, Gram-positive infections. Pharmacokinetic studies suggest that daptomycin could penetrate into the cerebrospinal fluid, albeit to a small extent. The objective of this review was to evaluate the available clinical evidence for the use of daptomycin in acute bacterial meningitis of both paediatric and adult patients.
Methods:
Electronic databases were searched up to June 2022 for studies published on the topic. The inclusion criteria were met if the study reported the use of intravenous daptomycin (more than a single dose) for the treatment of diagnosed acute bacterial meningitis.
Results:
In total, 21 case reports were identified that met the inclusion criteria. These suggest that daptomycin could be a safe and effective alternative to achieve clinical cure of meningitis. In these studies, daptomycin was used in the event of treatment failure, patient intolerance or bacterial resistance to first-line agents.
Conclusions:
Daptomycin has potential to be an alternative to standard care for meningitis caused by Gram-positive bacteria in the future. However, more robust research is required to establish an optimal dosing regimen, duration of therapy, and place in therapy for the management of meningitis.
Insights
Daptomycin shows promise as a safe treatment for bacterial meningitis, especially for drug-resistant Gram-positive infections. Further research is needed to define optimal use for this serious condition.
Area of Science:
- Infectious Diseases
- Pharmacology
- Neuroscience
Background:
- Growing interest in daptomycin for multi-drug-resistant Gram-positive infections.
- Pharmacokinetic data suggest limited cerebrospinal fluid penetration of daptomycin.
- Need to evaluate clinical evidence for daptomycin in bacterial meningitis.
Purpose of the Study:
- To review clinical evidence of daptomycin use in acute bacterial meningitis.
- To assess safety and efficacy in pediatric and adult patients.
- To identify potential role in managing resistant Gram-positive meningitis.
Main Methods:
- Systematic search of electronic databases up to June 2022.
- Inclusion of studies reporting intravenous daptomycin use (multiple doses).
- Focus on diagnosed cases of acute bacterial meningitis.
Main Results:
- 21 case reports met inclusion criteria.
- Daptomycin demonstrated safety and efficacy in achieving clinical cure.
- Used primarily for treatment failure, intolerance, or resistance to first-line agents.
Conclusions:
- Daptomycin may offer an alternative for Gram-positive bacterial meningitis.
- More research is essential to establish optimal dosing and duration.
- Further studies needed to define daptomycin's place in meningitis management.
Related Concept Videos
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
01:29Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
01:27Acute Pyelonephritis I: Introduction
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: